Oligodendrocyte cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes from apoptosis by

Cornelia Cudrici1, Teodora Niculescu, Florin Niculescu

  • 1Department of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

Insights

Multiple sclerosis involves immune attacks on oligodendrocytes. Complement C5b-9 promotes demyelination in acute MS but may protect these cells in chronic stages.

Area of Science:

  • Neuroimmunology
  • Demyelinating Diseases

Background:

  • Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease.
  • Immune cells and complement system mediate attacks on myelin-forming oligodendrocytes (OLGs).
  • OLG death contributes to demyelination and cell loss in MS plaques.

Purpose of the Study:

  • To investigate the role of complement activation in oligodendrocyte death and demyelination in MS.
  • To elucidate the dual role of complement C5b-9 in acute versus chronic MS pathogenesis.

Main Methods:

  • Studies utilized experimental allergic encephalomyelitis (EAE) models in mice.
  • Experiments involved caspase 11-deficient and C5-deficient mice.
  • Analysis of oligodendrocyte apoptosis, necrosis, and demyelination.

Main Results:

  • Caspase-mediated OLG death is critical for demyelination in EAE.
  • Complement C5b-9 promotes demyelination via the terminal complex.
  • Sublytic C5b-9 protects OLGs from apoptosis, while C5 promotes axon preservation and remyelination.

Conclusions:

  • Activated complement C5b-9 has a dual role in MS pathogenesis.
  • C5b-9 is proinflammatory in acute MS, contributing to demyelination.
  • C5b-9 may offer protection against OLG death in chronic MS through promoting remyelination.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...